Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials – A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting

This publication has 57 references indexed in Scilit:

• Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab
  Pediatric Blood & Cancer, 2013
• Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients
  European Journal of Cancer, 2012
• Genomic profiling by whole‐genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse
  Genes, Chromosomes and Cancer, 2012
• Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene
  Nature Reviews Cancer, 2011
• Treatment of relapsed Wilms tumors: lessons learned
  Expert Review of Anticancer Therapy, 2009
• Topotecan Is Active Against Wilms’ Tumor: Results of a Multi-Institutional Phase II Study
  Journal of Clinical Oncology, 2007
• Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
  Pediatric Blood & Cancer, 2007
• Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study Group
  Pediatric Blood & Cancer, 2007
• Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour
  The Journal of Pathology, 2006
• The survivin: Fas ratio in pediatric renal tumors
  Journal of Pediatric Surgery, 2001